Moreover, several markers of inflammation have been associated with increased tumor burden and/or adverse outcome in ovarian cancer, including high neutrophil-to-lymphocyte ratio [19]; high monocyte count [26]; elevated C-reactive protein and hypoalbuminaemia [27]; and elevated IL-6 and IL-8 levels in ascites fluid [28,29]. The gene discussed is CRP; the disease is neoplasm.